Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. We are committed to bringing Better Health and a Brighter Future to people worldwide by translating science into highly innovative medicines. Takeda focuses on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology, with targeted investments in Plasma-Derived Therapies and Vaccines.